Newsroom | 57431 results

ニュージャージー州プリンストン--(BUSINESS WIRE)--（ビジネスワイヤ） -- ニュージャージー州プリンストンに本社を置く主要な受託研究および臨床製造サービスプロバイダーであるNJバイオは、L2Pリサーチラボ®（「Lab to Pharmacy」）の研究サービスの資産取得と完全統合を発表しました。これにより、同社のサービス・ポートフォリオがさらに拡大し、トランスレーショナル・リサーチのギャップを解消します。 現在、生物学的分子が第1相臨床試験を通過する際の脱落率は非常に高く、この課題を克服するための鍵はトランスレーショナル・リサーチにあります。NJバイオは、非臨床および初期段階の臨床研究開発を専門としており、主にADC（抗体薬物複合体）、バイオコンジュゲーション、カスタム合成、オリゴヌクレオチド、mRNAに重点を置いています。しかし、同社が顧客に提供するトランスレーショナル・リサーチのサービスにはこれまで空白がありました。今回、L2Pのサービスの資産取得および統合により、NJバイオは非臨床からトランスレーショナル・リサーチに至る包括的な研究サービス群を一つの枠組みの下で...

LOS ANGELES--(BUSINESS WIRE)--City of Hope today announced that Dr. Christine M. Lovly will spearhead the development of its new national thoracic oncology program starting Jan. 1....

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 21, 2025, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units (“RSUs”) representing 184,961 shares of its common stock to 272 new non-executive employees and one non-qualified stock option award to purchase 5,731 shares of its common stock to one new non-executive employee with a grant date of Octobe...

BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (TSX: ANRG | OTCQX: ANRGF) will release Q3 2025 results Nov 11 after market close; conference call Nov 12 at 10 a.m. ET....

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading quantum company, today announced its selection for Stage B of the Defense Advanced Research Projects Agency (DARPA)’s Quantum Benchmarking Initiative (QBI). This selection follows IonQ’s successful completion of Stage A, where the company detailed its utility-scale quantum computing plans. As a participant in QBI, IonQ plays a critical role in defining what it means for a quantum computer to achieve utility-scale perform...

COLLEGE PARK (Maryland), USA.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), världens ledande kvantdatorföretag, har i samarbete med välrenommerade schweiziska partner implementerat ett stadsövergripande kvantnätverk i Schweiz näst största stad, Genève. Detta konsortium av världsledande akademiska institutioner, företag och organ i offentlig sektor kommer att utveckla forskning, samarbete och innovation inom kvantdatasäkerhet och -kommunikation. Den nya infrastrukturen, som fått namnet Geneva Quantum Net...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference being held from December 2-4, 2025. Details of the event are as follows: Eric Easom, Co-Founder, Chairman, President and...

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral genetic medicines company, today announced that management will participate in the following investor conferences in November: Guggenheim 2nd Annual Healthcare Innovation Conference Date: Tuesday, November 11, 2025 Time: 12:30 p.m. ET Stifel 2025 Healthcare Conference Date: Wednesday, November 12, 2025 Time: 2:00 p.m. ET Jefferies Global Healthcare Conference in London Date: Tuesday,...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on January 15, 2026, to shareholders of record as of December 15, 2025. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world he...